Mechanism
CD20-directed Cytolytic Antibody
Assets acting on this target.
- Class
- CD20-directed Antibody Interactions
- Notes
- openFDA EPC fill 2026-08-24 (exact-name label match: Rituximab); source: https://api.fda.gov/drug/label.json?search=openfda.generic_name%3A%22Rituximab%22+openfda.brand_name%3A%22Rituximab%22&limit=12&api_key=y2ronyIZO6JYMBCLxUKFvKtreygS8ZGhn3itfuqo